Literature DB >> 31501146

A Rare D94F Change in gyrA Gene of Multidrug-Resistant Mycobacterium tuberculosis Possibly Contributing to an Unfavorable Treatment Outcome.

Rakesh Yadav1, Aastha Saini1, Priyanka Agarwal2, Pooja Kapoor2, Ashutosh N Aggarwal3, Sunil Sethi4.   

Abstract

Entities:  

Keywords:  drug resistance; fluoroquinolones; rare mutations; tuberculosis

Mesh：

Substances：

Year:  2019        PMID： 31501146      PMCID： PMC6811423          DOI： 10.1128/AAC.01312-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Reduction of minimum inhibitory concentrations in drug-resistant Mycobacterium tuberculosis isolates in the presence of efflux pump inhibitors.

Authors:  Rakesh Yadav; Sunil Kumar Dhatwalia; Abhishek Mewara; Digambar Behera; Sunil Sethi
Journal:  J Glob Antimicrob Resist       Date:  2015-12-08       Impact factor: 4.035

2.  Using Mycobacterium tuberculosis Single-Nucleotide Polymorphisms To Predict Fluoroquinolone Treatment Response.

Authors:  Marva Seifert; Edmund Capparelli; Donald G Catanzaro; Timothy C Rodwell
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

3.  Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.

Authors:  Lulette Tricia C Bravo; Marion J Tuohy; Concepcion Ang; Raul V Destura; Myrna Mendoza; Gary W Procop; Steven M Gordon; Geraldine S Hall; Nabin K Shrestha
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

4.  Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009.

Authors:  Zhenling Cui; Jie Wang; Junmei Lu; Xiaochen Huang; Zhongyi Hu
Journal:  BMC Infect Dis       Date:  2011-03-29       Impact factor: 3.090

5.  A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.

Authors:  Paolo Miotto; Belay Tessema; Elisa Tagliani; Leonid Chindelevitch; Angela M Starks; Claudia Emerson; Debra Hanna; Peter S Kim; Richard Liwski; Matteo Zignol; Christopher Gilpin; Stefan Niemann; Claudia M Denkinger; Joy Fleming; Robin M Warren; Derrick Crook; James Posey; Sebastien Gagneux; Sven Hoffner; Camilla Rodrigues; Iñaki Comas; David M Engelthaler; Megan Murray; David Alland; Leen Rigouts; Christoph Lange; Keertan Dheda; Rumina Hasan; Uma Devi K Ranganathan; Ruth McNerney; Matthew Ezewudo; Daniela M Cirillo; Marco Schito; Claudio U Köser; Timothy C Rodwell
Journal:  Eur Respir J       Date:  2017-12-28       Impact factor: 16.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.